These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31234332)

  • 21. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
    Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
    Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eribulin sensitizes oral squamous cell carcinoma cells to cetuximab via induction of mesenchymal-to-epithelial transition.
    Kitahara H; Hirai M; Kato K; Bou-Gharios G; Nakamura H; Kawashiri S
    Oncol Rep; 2016 Dec; 36(6):3139-3144. PubMed ID: 27779690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels.
    Tonigold M; Rossmann A; Meinold M; Bette M; Märken M; Henkenius K; Bretz AC; Giel G; Cai C; Rodepeter FR; Beneš V; Grénman R; Carey TE; Lage H; Stiewe T; Neubauer A; Werner JA; Brendel C; Mandic R
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1689-704. PubMed ID: 24913304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of p53 status on the synergistic effect of CKD-602 and cisplatin on oral squamous cell carcinoma cell lines.
    Choi HS; Kim YK; Yun PY
    Mol Biol Rep; 2019 Feb; 46(1):617-625. PubMed ID: 30478746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PER2 binding to PDK1 enhances the cisplatin sensitivity of oral squamous cell carcinoma through inhibition of the AKT/mTOR pathway.
    Zheng H; Yu W; Ren J; Tang H; Li H; Zhang Z; Yin S; Yang K
    Cell Signal; 2024 Oct; 122():111327. PubMed ID: 39079621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma.
    Ota T; Jono H; Ota K; Shinriki S; Ueda M; Sueyoshi T; Nakatani K; Hiraishi Y; Wada T; Fujita S; Obayashi K; Shinohara M; Ando Y
    Oncol Rep; 2012 May; 27(5):1674-80. PubMed ID: 22344722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells.
    Han ML; Zhao YF; Tan CH; Xiong YJ; Wang WJ; Wu F; Fei Y; Wang L; Liang ZQ
    Acta Pharmacol Sin; 2016 Dec; 37(12):1606-1622. PubMed ID: 27840408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma.
    Li L; Liu HC; Wang C; Liu X; Hu FC; Xie N; Lü L; Chen X; Huang HZ
    Biomed Res Int; 2016; 2016():5378567. PubMed ID: 27529071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma.
    de Castro LR; de Oliveira LD; Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida OGG; Amorim MLM; Squarize CH; Castilho RM; de Almeida LO
    J Cell Physiol; 2024 Feb; 239(2):e31164. PubMed ID: 38149816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of a cisplatin-induced multidrug resistance cell line SK-Hep1/DDP.
    Zhou Y; Ling XL
    Chin J Cancer; 2010 Feb; 29(2):167-71. PubMed ID: 20109345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.
    Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J
    Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
    Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Insight into the role of IGF2BP1 in drug resistant mechanism of oral squamous cell carcinoma].
    Xie F; Qin X; Tong T; Jiang YY; Zhang JJ
    Shanghai Kou Qiang Yi Xue; 2021 Oct; 30(5):456-461. PubMed ID: 34888594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Iwata E; Hasegawa T; Takeda D; Ueha T; Kawamoto T; Akisue T; Sakai Y; Komori T
    Int J Oncol; 2016 Apr; 48(4):1493-8. PubMed ID: 26846904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
    Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
    Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.
    Januchowski R; Sterzyńska K; Zaorska K; Sosińska P; Klejewski A; Brązert M; Nowicki M; Zabel M
    J Ovarian Res; 2016 Oct; 9(1):65. PubMed ID: 27756418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FaDu cell characteristics induced by multidrug resistance.
    Ma J; Lu S; Yu L; Tian J; Li J; Wang H; Xu W
    Oncol Rep; 2011 Nov; 26(5):1189-95. PubMed ID: 21833476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.